MEDP
Medpace Holdings Inc
NASDAQ: MEDP · HEALTHCARE · DIAGNOSTICS & RESEARCH
$413.59
+0.96% today
Updated 2026-04-29
Market cap
$11.81B
P/E ratio
26.04
P/S ratio
4.41x
EPS (TTM)
$15.88
Dividend yield
—
52W range
$284 – $629
Volume
0.4M
Medpace Holdings Inc (MEDP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $98.14M | $75.20M | $85.87M | $91.73M | $97.39M | $156.58M | $201.87M | $258.68M | $263.33M | $388.05M | $433.37M | $608.82M | $713.22M |
| Capital expenditures | $4.56M | $5.32M | $6.46M | $13.54M | $12.29M | $16.02M | $17.91M | $31.34M | $28.27M | $36.88M | $36.65M | $36.55M | $31.36M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.96M | $12.76M | $22.32M | $9.81M | $4.46M | $6.50M | $20.74M | $13.78M | $14.47M | $21.41M | $20.52M | $25.51M | $34.79M |
| Free cash flow | $93.58M | $69.89M | $79.41M | $78.19M | $85.09M | $140.56M | $183.96M | $227.34M | $235.06M | $351.17M | $396.73M | $572.27M | $681.87M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | — | — | — | — | $22.07M | $11.38M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $19.67M | $-12.68M | $-1.97M | $108.81M | $145.18M | $187.51M | $-426.47M | — | — | — |